IO:GULF
Home
Principles
IO:GULF Team
Cancer Medicines Market
TCR bispecifics
IO:GULF
Home
Principles
IO:GULF Team
Cancer Medicines Market
TCR bispecifics
More
  • Home
  • Principles
  • IO:GULF Team
  • Cancer Medicines Market
  • TCR bispecifics
  • Home
  • Principles
  • IO:GULF Team
  • Cancer Medicines Market
  • TCR bispecifics

New Horizons in Oncology for the GCC

Gulf Designed and Manufactured Precision Cancer Medicines

About Immuno-Oncology:GULF

Transforming the Biotechnology Landscape in the Arabian Gulf

  • IO:GULF is an oncology medicines biotechnology project seeking funding within the GCC countries. 
  • Fully aligned to Economic Development Visions across the region.
  • Created by industry experts from Oxford, UK.  
  • IO:GULF will leverage it's co-founders unique clinical, scientific and commercial skills.
  • Establishing a locally headquartered research and development company focused on creating new precision oncology medicines.
  • A business designed to enter the global pharmaceutical market. 
  • Tailored to the genetic profile of the Arab population, whilst capturing a global market share. 
  • IO:GULF will become a strategic asset within a Gulf country, supporting and shaping a vision of being a global pharmaceutical powerhouse.

Contact Us

Contact Form:

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

If you represent an interested governmental, institutional or private investor, please contact us by either WhatsApp or e-mail below:

Message us on WhatsApp

jmitchell@iogulf.com

Copyright © 2025 IO:GULF - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept